​In the CY 2025 HOPPS Proposed Rule, CMS proposed a new reimbursement policy for diagnostic PET scans that would provide separate payment for radiopharmaceuticals that have a per-day cost of more the $630, as well as an extra payment for hospitals when they use domestically produced technetium-99m. If finalized, this new reimbursement policy would replace the existing policy in which diagnostic radiopharmaceuticals are considered supplies and packaged into the imaging procedure. It should be noted any diagnostic radiopharmaceutical with a per-day cost of less than $630 would continue to be packaged under the current policy.

Teleradiology facilitates the remote diagnosis and treatment of patients across the globe by providing a crucial component of telemedicine and revolutionizing the way diagnostic imaging services are delivered. This innovation enhances access to specialized imaging interpretation services and significantly improves the efficiency and reach of healthcare delivery. Teleradiology is beneficial to healthcare services in many ways. The utilization of teleradiology services can enable a facility to reduce its out-of-pocket costs, provide 24/7 radiological services, increase the number of physicians available for consultation, and expedite and improve patient care.